| Join us for a Webinar on Focused Ultrasound’s Potential Role in Neurofibromatosis Treatment
The Focused Ultrasound Foundation and the Children’s Tumor Foundation invite you to join a virtual panel discussion introducing focused ultrasound to the neurofibromatosis research community.
Four brief presentations will highlight the current challenges in neurofibromatosis type 2 (NF2) treatment and the potential of focused ultrasound to become a versatile clinical tool to treat a wide range of medical disorders, with a particular emphasis on focused ultrasound-enhanced drug delivery techniques. The subsequent discussion and Q&A will allow the panel of experts to begin to brainstorm how focused ultrasound may benefit NF2 patients as well as provide ample opportunity for questions from online participants.
We encourage you to join us Wednesday, August 12, at 11:00am Eastern and engage in the discussion.
ONLINE WEBINAR
Focused Ultrasound and its Potential Role in Neurofibromatosis Treatment
Wednesday, August 12, 2020
11:00 AM Eastern
REGISTER NOW >
Moderator
 |
Jessica Foley, PhD
Chief Scientific Officer, Focused Ultrasound Foundation |
Panelists
 |
Michel Kalamarides, MD, PhD
Professor of Neurosurgery, Pitié-Salpetrière Hôpital (Faculté de Medécine, Sorbonne- Université), Paris, France |
 |
AeRang Kim, MD, PhD
Associate Professor of Pediatrics, Solid tumors faculty member, Children’s National Hospital, Washington, DC |
 |
Nathan McDannold, PhD
Research Associate, Brigham and Women’s Hospital, Boston, MA Professor of Radiology, Harvard Medical School, Boston, MA |
 |
Tyrone Porter, PhD
Professor of Biomedical Engineering, University of Texas at Austin, Austin, TX |
Read more about each of the speakers >
|
